Overhaul of MSK research needed
11th February 2014
Funding for musculoskeletal (MSK) clinical trials in Australia is disproportionately low and many trials are not addressing the most critical issues, according to a new analysis.
While MSK conditions are the leading contributor to Australia’s disability burden, they attract only 0.8% of grants and funding from the National Health and Medical Research Council, the report published this week in the Medical Journal of